Related by context. Frequent words. (Click for all words.) 72 Qualifying Therapeutic Discovery 71 Therapeutic Discovery Project 71 QTDP 61 Orphan Drug designation 57 SBIR grant 57 Development Authority BARDA 56 Protexia R 55 KNS # 55 Orphan Drug Designation 54 Investigational Device Exemption 54 Nasdaq VRTX 54 Anthim 54 Fast Track Designation 54 Panzem R 54 Orphan Drug Status 54 Orphan Drug status 54 submitted Biologics License 53 Application BLA 53 orphan designation 53 SBIR Phase 53 Humanitarian Device Exemption 53 BioThrax R 52 Pivotal Phase III 52 NEUMUNE 52 CFFT 52 BioDelivery Sciences 52 ROTATEQ 51 Exclusive License 51 subcutaneous formulation 51 sodium Injection 51 raxibacumab 51 Assistance Program NRC IRAP 51 Section #D 51 Fibrillex TM 51 Biologics License Application BLA 51 Technology Transfer STTR 51 supplemental Biologics License Application 50 Rotarix R 50 Loan Guarantee Program 50 application sNDA 50 relapsing multiple sclerosis 50 Zelrix 50 Marketing Authorization Application 50 ATryn ® 50 ALN TTR# 50 forodesine 50 Solzira 50 Committed Equity 50 HCV protease inhibitor 50 Fast Track designation 50 liposomal formulation 49 Diabetic Macular Edema 49 Investigational Device Exemption IDE 49 Entereg R 49 BLA submission 49 Economic Opportunity DCEO 49 Issues Guidance 49 anticancer compound 49 Patient Assistance Program 49 Postdoctoral Fellowship 49 Combidex 49 IMVAMUNE R 49 ZALBIN 49 AeroLEF 49 registrational 49 AeroLEF TM 49 Program EQIP 49 NASDAQ DYAX 49 Eligard R 49 BioMarin Genzyme LLC 49 Allovectin 7 R 49 Project BioShield Act 49 pseudobulbar affect PBA 49 Reintegration Program 48 Onalta 48 elotuzumab 48 Aerosurf 48 Icatibant 48 Marketing Authorization Application MAA 48 CBLB# 48 Abstral 48 Orphan Drug 48 IND submission 48 Protectan CBLB# 48 Broadband Initiatives 48 Adequate Fire 48 Phase IIB 48 GSA Contract 48 INDs 48 NASDAQ BPAX 48 Burroughs Wellcome Fund 48 refractory Hodgkin lymphoma 48 AnGes 48 BEMA Buprenorphine 48 Phase IIb trials 48 SBIR grants 48 phase IIb clinical 48 Cethrin 48 injectable formulation 48 CDFI Fund 48 confirmatory Phase III